Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.24
Delayed Data
As of 10:06am ET
 -0.05 / -3.88%
Today’s Change
1.13
Today|||52-Week Range
2.17
-1.59%
Year-to-Date
No recent news for ArQule Inc.

Today’s Trading

Previous close1.29
Today’s open1.27
Day’s range1.23 - 1.27
Volume775,389
Average volume (3 months)163,635
Market cap$91.7M
Dividend yield--
Data as of 10:06am ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+40.54%
Earnings growth (this year)-50.00%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-0.13%
P/E ratioNM
Price/Sales12.13
Price/Book2.78

Competitors

 Today’s
change
Today’s
% change
SYNSynthetic Biologics ...-0.00-0.43%
AFMDAffimed NV0.000.00%
GEMPGemphire Therapeutic...+0.19+1.94%
CPIXCumberland Pharmaceu...-0.29-5.19%
Data as of 10:04am ET, 02/22/2017

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$11.2M
Annual profit (last year)-$13.8M
Net profit margin-122.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President, COO, Secretary &
General Counsel
Peter S. Lawrence
Corporate headquarters
Burlington, Massachusetts

Forecasts


Search for Jobs